Literature DB >> 20130446

The promise of novel androgen receptor antagonists.

Daniel G Gioeli1.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20130446     DOI： 10.4161/cc.9.3.11045

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

1.  CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylation.

Authors:  Vicki Gordon; Shriti Bhadel; Winfried Wunderlich; JoAnn Zhang; Scott B Ficarro; Sahana A Mollah; Jeffrey Shabanowitz; Donald F Hunt; Ioannis Xenarios; William C Hahn; Mark Conaway; Michael F Carey; Daniel Gioeli
Journal:  Mol Endocrinol       Date:  2010-10-27

2.  Androgen receptor serine 81 mediates Pin1 interaction and activity.

Authors:  Raffaele La Montagna; Isabella Caligiuri; Pasquale Maranta; Chiara Lucchetti; Luca Esposito; Marco G Paggi; Giuseppe Toffoli; Flavio Rizzolio; Antonio Giordano
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

3.  Galbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells.

Authors:  Yong Zhang; Kwan-Hyun Kim; Wei Zhang; Yinglu Guo; Sung-Hoon Kim; Junxuan Lü
Journal:  Int J Cancer       Date:  2011-05-09       Impact factor: 7.396

4.  Checkpoint Kinase 2 Negatively Regulates Androgen Sensitivity and Prostate Cancer Cell Growth.

Authors:  Huy Q Ta; Melissa L Ivey; Henry F Frierson; Mark R Conaway; Jaroslaw Dziegielewski; James M Larner; Daniel Gioeli
Journal:  Cancer Res       Date:  2015-11-16       Impact factor: 12.701

Review 5.  Recent progress in targeting cancer.

Authors:  Zoya N Demidenko; James A McCubrey
Journal:  Aging (Albany NY)       Date:  2011-12       Impact factor: 5.682

6.  Identification of kinases regulating prostate cancer cell growth using an RNAi phenotypic screen.

Authors:  Hilary Whitworth; Shriti Bhadel; Melissa Ivey; Mark Conaway; Andrea Spencer; Ronald Hernan; Heather Holemon; Daniel Gioeli
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

7.  The Influence of Androgen Deprivation Therapy on Prostate Size and Voiding Symptoms in Prostate Cancer Patients in Korea.

Authors:  Hoon Choi; Hong Chung; Jae Young Park; Jeong Gu Lee; Jae Hyun Bae
Journal:  Int Neurourol J       Date:  2016-12-26       Impact factor: 2.835
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.